DUSA
DUSA Pharmaceutical develops dermatology products for the treatment of actinic keratoses and acne.
Business Model:
Revenue: $10M
Employees: 51-200
Rankings
Industries / Tags:
Detailed DUSA Information
DUSA was acquired by
Sun Pharma.
The acquisition happend on 2012-11-09.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 25 Upton Dr
City: Wilmington
State: MA
Zip: 01887
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$25M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
DUSA Pharmaceutical develops dermatology products for the treatment of actinic keratoses and acne.
Contact Phone:
+19786577500
Contact Email:
DUSA went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
DUSA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2004 | Equity | $24.8M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
